Displaying articles by keyword Ventricular assist device

ISSN 2304-7232

Cardiometric diagnostics and control of anti-androgenic drug adverse effects…

Capabilities of the cardiometric diagnostics based on the heart cycle phase analysis for identifying the primary cause of a disease…

The effects of long-term microgravity on autonomic regulation of…

The article presents the results of space experiment “Pneumocard”. The investigation involved all 25 Russian members of the ISS crew.…

Occurrence of HLA- and non-HLA antibodies after heart transplantation…

Cardiac allograft vasculopathy (CAV) accounts for major morbidity and mortality late in the heart transplant (HTx) history. The role of…

Diagnostic value of measured hemodynamic parameters: cardiac output, minute…

The paper reviews the existing methods for hemodynamic parameters measurement, namely the Fick method, the thermodilution technique and the Cardiocode…

Identification of non-HLA antibodies in ventricular assist device recipients

Published in No.3 November 2013

Recipients of ventricular assist devices (VADR) have a higher incidence to develop antibodies (Abs) against human leukocyte antigens (HLA). Non-HLA antibodies like major histocompatibility complex class I-related chain A (MICA) and autoantibodies against angiotensin type 1 receptor (AT1R) and endothelin receptor A (ETAR) are also implicated in the pathogenesis of acute rejection and allograft vasculopathy. We monitored non-HLA- and HLA-Abs in VADR up to one year after implantation.